Evan Rachlin
Angel · California
Board director at 3 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jul 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Cardurion PharmaceuticalsJul 24, 2024
- SEC Form D: Iambic TherapeuticsOct 12, 2023
- SEC Form D: OrsoBioNov 13, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.